-
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Informational Webinar for PAR-23-138 "Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Update to Policy and Procedures for the Reporting of Human Subjects Enrollment Data for NIA Clinical Research Trials/Studies
at National Institutes of Health in United States -
- Contract/Tender
- Posted 1 year ago
Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology
at National Institutes of Health in United States -
- Contract/Tender
- Posted 1 year ago
Notice of Termination of RFA-TR-22-011 HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Special Interest (NOSI): EXposome in Autoimmune Disease Collaborating Teams PLANning Awards (EXACT-PLAN) (Clinical Trials Not Allowed)
at National Institutes of Health in United States -
- Contract/Tender
- Posted 1 year ago
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications.
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Notice of Change in Funding Opportunity Purpose of NIDCR Small Research Grants for Analyses of Existing Genomics Data (PAR-23-132)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Change of the Locus of Review, Application Types Allowed and Expiration date for PAR-23-097, "Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Termination of PAR-22-100 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Termination of PAR-22-101 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Intent to Publish a Notice of Funding Opportunity for the PATCH-IN Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Change of the Locus of Review for PAR-23-102, "Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Correction to Section IV. Application and Submission Information for RFA-NS-24-022 "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of NIDCD Participation in PAR-21-251 "Emerging Global Leader Award (K43 Independent Clinical Trial Required)" and PAR-21-252 Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Change to Application and Submission Information in RFA-AI-22-076, Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required)
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Clarification to Eligibility Criteria for PAR-22-265 "Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Undergraduate Scholarship
- Posted 1 year ago
Notice to Extend the Expiration Date of RFA-HG-22-004: Genome Research Experiences to Attract Talented Undergraduates into Genomic Fields to Enhance Diversity (R25 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Contract/Tender
- Posted 1 year ago
Notice of Special Interest (NOSI): Administrative Supplements to Study the Economics of Cancer Control in Low- and Middle-Income Countries (LMICs)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of NHLBI Participation in PAR-23-067, Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Human Pangenome Coordinating Center (U41) Clinical Trial Not Allowed
at National Institutes of Health in United States